Chronic Kidney Disease
Part of NephTimes
There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes. AI technology to detect elevated CKD risk in people with diabetes received Breakthrough Device designation from the FDA. How does sodium bicarbonate affect bone health markers in patients with chronic kidney disease (CKD)? Researchers explored the association between CSVD and CKD plus the potential role of hypertension in this association. Researchers examined use of clinical decision support systems to decrease blood pressure in hypertensive patients with CKD. Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD). The ERA reviewed phase 3 trials to clarify the mechanism behind HIF-PHi and their role in managing CKD-related anemia. Research has begun to question recommendations to restrict potassium with CKD to manage hyperkalemia. A super-learner strategy gave accurate risk predictions of kidney failure and death for people with moderate to severe CKD. Researchers uncovered clinical and economic of the Kidney BEAM physical activity digital health intervention for CKD. Use of antidepressants among patients with CKD is widespread but few data are available on their safety in this population. Few data are available on the role of statins for preventing ASCVD in patients with moderate chronic kidney disease. A simulation model predicts a dramatic increase in the impact of chronic kidney disease in the next 10 years. Kavita Mistry and Marcelle Tuttle will be the American Kidney Fund 2024 Clinical Scientist in Nephrology Fellows. The RPA and ASN called for a halt in reductions to Medicare payments to nephrology practices participating in the KCC model. A group of experts including the ASN, ERA, and ISN joined together to push for global action on chronic kidney disease (CKD). Yanlin Wang of UConn Health has won the VA's Senior Clinician Scientist Investigator Award. A whole food, plant-based diet has shown benefits for patients with chronic kidney disease (CKD). Since the onset of the pandemic, cardiovascular complications have been seen in patients with CKD and COVID-19. SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.